London-based BenevolentAI, which uses drug industry data and research to discover new drug applications, highlights the promise of AI in fight against COVID-19 (Tom Simonite/Wired)

Tom Simonite / Wired:
London-based BenevolentAI, which uses drug industry data and research to discover new drug applications, highlights the promise of AI in fight against COVID-19  —  Software suggested an arthritis drug might quell an out-of-control immune response that damages the lungs.  Now it’s being tested in a clinical trial.